The collaboration will combine Firstsource’s AI-first approach with Guidehealth’s expertise in value-based care innovation
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A
Diltiazem works by relaxing blood vessels, which reduces the workload on the heart and increases blood and oxygen supply to the heart muscle
Prucalopride is prescribed for chronic idiopathic constipation
During this quarter, the company achieved a key milestone of reaching 1,000 DCGI approvals
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
This is the group’s first NoC approval in Canada
Athena is also exploring the use of this technology for expanded carrier screening
The companies will now begin detailed contract negotiations and proceed with necessary consultations and approval processes
Subscribe To Our Newsletter & Stay Updated
